QGel
Reproducing human physiology
QGel has raised €11M across 1 funding round, most recently a Growth/Late round in Dec 2016. Based in Lausanne, Switzerland; founded 2009; active in Healthtech. Data as of Nov 2026.
Total raised
€11M
€10,920,000
Funding rounds
1
Investors
0
distinct backers
Active since
2016-12
latest 2016-12
Funding by year
EUR raised per yearQGel — funding by year — interactive chart.
Data table
| QGel — funding by year | |
|---|---|
| 2016 | €11M |
Signals
Medium confidenceRaise-next likelihood7
base rate 37% for Growth/Late
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-12-01 | Growth/Late | €11M | — | View deal → |
Related news
Similar companies
same sector, similar size- ProteoMediX€10MSwitzerland · Healthtech
- Modum€8.7MSwitzerland · Healthtech
- Pristem€12MSwitzerland · Healthtech
- Kuros€15MSwitzerland · Healthtech
- Alentis Therapeutics€11MSwitzerland · Healthtech
- Kuros Biosurgery€26MSwitzerland · Healthtech
Global coverage: FundingData